<DOC>
<DOCNO>EP-0618797</DOCNO> 
<TEXT>
<INVENTION-TITLE>
PHARMACEUTICAL PREPARATIONS CONTAINING BILOBALID FOR THE TREATMENT OF NERVOUS TENSION AND ANXIETY
</INVENTION-TITLE>
<CLASSIFICATIONS>A61P2522	A61P2524	C07D49300	A61P2520	A61K31365	A61P2500	A61P2526	A61K3600	A61K3600	C07D49314	A61K31365	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61P	A61P	C07D	A61P	A61K	A61P	A61P	A61K	A61K	C07D	A61K	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61P25	A61P25	C07D493	A61P25	A61K31	A61P25	A61P25	A61K36	A61K36	C07D493	A61K31	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
Proposed is a new medical application for bilobalid in pure form, or for Ginkgo biloba extract with an elevated bilobalid content, as an anxiolytic or antidepressant.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
SCHWABE WILLMAR GMBH 
&
 CO
</APPLICANT-NAME>
<APPLICANT-NAME>
DR. WILLMAR SCHWABE GMBH 
&
 CO.
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
CHATTERJEE SHYAM S
</INVENTOR-NAME>
<INVENTOR-NAME>
NOELDNER MICHAEL
</INVENTOR-NAME>
<INVENTOR-NAME>
CHATTERJEE, SHYAM, S.
</INVENTOR-NAME>
<INVENTOR-NAME>
NOELDNER, MICHAEL
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
Use of bilobalid or of Gingko biloba extracts enriched with
bilobalid for the preparation of a pharmaceutical composition

for the treatment or prophylaxis of anxiety, nervous tension
and depressive diseases, said conditions or diseases not being

induced by cerebrovascular insufficiency if Gingko biloba
extracts enriched with bilobalid are used.
</CLAIMS>
</TEXT>
</DOC>
